Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04464590
What this trial is testing

Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

Who this might be right for
Malignant LymphomaRelapsed Non Hodgkin LymphomaRelapsed Hodgkin's Disease, Adult+1 more
University Hospital, Brest 100
Testing effectiveness (Phase 2)Study completedNCT00743782
What this trial is testing

Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism

Who this might be right for
HypoparathyroidismHypocalcemiaAutoimmune Polyendocrine Syndrome Type 1+1 more
National Institutes of Health Clinical Center (CC) 21
Early research (Phase 1)Ended earlyNCT03360006
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 30
Not applicableLooking for participantsNCT03528226
What this trial is testing

Exercise Training and Endothelial Function in Type 1 Diabetes

Who this might be right for
Type1diabetes
University Hospital, Lille 34
Early research (Phase 1)Study completedNCT01328626
What this trial is testing

Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
AbbVie 222
Early research (Phase 1)Study completedNCT00889408
What this trial is testing

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 25
Early research (Phase 1)Study completedNCT01407315
What this trial is testing

Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor

Who this might be right for
Type 1 Diabetes
Medical University of Graz 20
Not applicableStudy completedNCT01168076
What this trial is testing

Noninvasive Transcutaneous Glucometer Development

Who this might be right for
HealthyPrediabetic State (IGT)Diabetes Mellitus, Type 2+1 more
InLight Solutions 500
Testing effectiveness (Phase 2)Study completedNCT04585776
What this trial is testing

LY900014 and Insulin Degludec in Participants With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Eli Lilly and Company 31
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableLooking for participantsNCT07104292
What this trial is testing

Pelvic Floor Muscle Training During Pregnancy

Who this might be right for
Pelvic FloorUrinary IncontinenceAnal Incontinence+2 more
University of Southern Denmark 734
Not applicableStudy completedNCT01293344
What this trial is testing

Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women

Who this might be right for
Cardiovascular Diseases
Laval University 70
Not applicableActive Not RecruitingNCT04982393
What this trial is testing

BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

Who this might be right for
Primary Hyperoxaluria Type 1
Alnylam Pharmaceuticals 207
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Not applicableUnknownNCT04858243
What this trial is testing

Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi

Who this might be right for
Hiv
University of California, Los Angeles 930
Early research (Phase 1)Study completedNCT02582840
What this trial is testing

The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 42
Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Not applicableStudy completedNCT01689090
What this trial is testing

Diameter Changes of Retinal Vessels During Hypoxia

Who this might be right for
Diabetes Mellitus Type 1Diabetic Maculopathy
University of Aarhus 58
Not applicableStudy completedNCT00699179
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,308
Not applicableStudy completedNCT04807374
What this trial is testing

Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Children's National Research Institute 15
Next Page